Shamburg News · 8-K filed Nov 6, 2026, 5:26 PM EST
Rallybio Postpones Avenzo Merger Closing and Delays Cash Distribution Funding
RLYB · Rallybio Corp
- Other event
- Acquisition
- Materiality: high
Rallybio Corporation stated that the closing of its merger with Avenzo Therapeutics, Inc. under the May 31, 2026 Merger Agreement has been postponed because certain conditions related to the listing of its shares after closing were not satisfied. The company did not deposit funds for the previously announced cash distribution with Computershare on November 5, 2026, so the payment date and ex-dividend date may be delayed. Rallybio said it will provide further updates as appropriate.
Source: SEC EDGAR, Form 8-K, Item 8.01, accession 0001193125-26-452115.
Written from the filing by Shamburg Markets. Figures are as reported by the company.